Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer Disease

Hai V. Nguyen, Shweta Mital, David S. Knopman, G. Caleb Alexander

View at source ↗Article82 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1212/wnl.0000000000209218
Published
Mar 14, 2024
Venue
Neurology
DOI
10.1212/wnl.0000000000209218
PubMed
38484190
Categories
Health Systems, Economic Evaluations, Quality of Life
Provenance
openalex

Topics